Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Da Silva-Gane

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Nephrology|October 28, 2015
A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysisKarin Friedli, Michael Almond, Clara Day, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 21, 2018
Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scoresAndrew Davenport, Ayman Guirguis, Michael Almond, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2017
Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility TrialKarin Friedli, Ayman Guirguis, Michael Almond, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 18, 2014
Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trialVari Wileman, Ken Farrington, Joseph Chilcot, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 2, 2017
Depression Symptoms in Haemodialysis Patients Predict All-Cause Mortality but Not Kidney Transplantation: A Cause-Specific Outcome AnalysisJoseph Chilcot, Ayman Guirguis, Karin Friedli, et al.
Psychology & Health|August 7, 2015
Evidence of improved fluid management in patients receiving haemodialysis following a self-affirmation theory-based intervention: A randomised controlled trialVari Wileman, Joseph Chilcot, Christopher J Armitage, et al.
BMJ Open|March 17, 2021
Outcomes and care priorities for older people living with frailty and advanced chronic kidney disease: a multiprofessional scoping review protocolHelen Hurst, Elizabeth Jones, Paula Ormandy, et al.
Plos One|April 7, 2023
The use of culturally adapted and translated depression screening questionnaires with South Asian haemodialysis patients in EnglandShivani Sharma, Sam Norton, Kamaldeep Bhui, et al.
Journal of Nephrology|December 20, 2023
Impact of COVID-19 on patient experience of kidney care: a rapid reviewLucy Mackintosh, Paula Ormandy, Amanda Busby, et al.
BMC Nephrology|December 4, 2023
Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centresLucy Mackintosh, Amanda Busby, Ken Farrington, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Nephrology|October 28, 2015
A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysisKarin Friedli, Michael Almond, Clara Day, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 21, 2018
Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scoresAndrew Davenport, Ayman Guirguis, Michael Almond, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 28, 2017
Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility TrialKarin Friedli, Ayman Guirguis, Michael Almond, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 18, 2014
Evidence that self-affirmation improves phosphate control in hemodialysis patients: a pilot cluster randomized controlled trialVari Wileman, Ken Farrington, Joseph Chilcot, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 2, 2017
Depression Symptoms in Haemodialysis Patients Predict All-Cause Mortality but Not Kidney Transplantation: A Cause-Specific Outcome AnalysisJoseph Chilcot, Ayman Guirguis, Karin Friedli, et al.
Psychology & Health|August 7, 2015
Evidence of improved fluid management in patients receiving haemodialysis following a self-affirmation theory-based intervention: A randomised controlled trialVari Wileman, Joseph Chilcot, Christopher J Armitage, et al.
BMJ Open|March 17, 2021
Outcomes and care priorities for older people living with frailty and advanced chronic kidney disease: a multiprofessional scoping review protocolHelen Hurst, Elizabeth Jones, Paula Ormandy, et al.
Plos One|April 7, 2023
The use of culturally adapted and translated depression screening questionnaires with South Asian haemodialysis patients in EnglandShivani Sharma, Sam Norton, Kamaldeep Bhui, et al.
Journal of Nephrology|December 20, 2023
Impact of COVID-19 on patient experience of kidney care: a rapid reviewLucy Mackintosh, Paula Ormandy, Amanda Busby, et al.
BMC Nephrology|December 4, 2023
Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centresLucy Mackintosh, Amanda Busby, Ken Farrington, et al.
Pageof 4